Community-acquired pneumonia is life-threatening and timely administration of antibiotics is a goal of therapy
In-hospital mortality associated with community-acquired pneumonia is comparable to that with acute myocardial infarction.
1 Patients with suspected community-acquired pneumonia require urgent assessment and therapy; however, overemphasis on time to first dose of antibiotics may lead to unnecessary administration of antibiotics for noninfectious diseases.
2 Because of a lack of convincing evidence, guidelines no longer specify a four-hour window for starting antibiotics for patients who require admission to hospital but instead recommend that the first dose be given in the emergency department.
2,3
Pretreatment diagnostic tests should be requested on a case-by-case basis Routine cultures of blood and sputum are controversial because of their low yield and impact on treatment decisions. These tests are optional for outpatients; however, they should be ordered for patients who require admission to hospital, even in the absence of fever, if there is an increased risk of unusual or resistant pathogens that would require a change of empiric therapy or duration. This includes patients with severe community-acquired pneumonia, an immunocompromised state, alcohol abuse, structural lung disease, the presence of a pleural effusion and those who have recently travelled, as well as those for whom outpatient therapy has failed. The presence of three or more of these criteria has recently been validated in a prospective observational trial for predicting need for intensive care.
4
Determining who can receive treatment as an outpatient should be guided by validated scoring systems Predictive scores including the CURB-65 (Confusion, Uremia, Respiratory rate, low Blood pressure, age ≥ 65 years) or Pneumonia Severity Index are useful for identifying those at low risk of death who may be safely cared for as outpatients.
3 A patient's oxygen saturation (Sp0 2 ) on room air is increasingly recognized as a stand-alone criterion for discharge decisions. A recent prospective cohort study of 2923 patients with community-acquired pneumonia showed that those discharged from the emergency department with an Sp0 2 of less than 90% had increased combined 30-day mortality and admission rates (odds ratio 1.7; 95% confidence interval 1.1-2.8; p = 0.032).
5 When an Sp0 2 of 92% or greater was used, the association with adverse events was no longer present.
Outpatient therapy should take into account risk factors for drugresistant Streptococcus pneumoniae
Patients with exposure to mac ro lides, trimethoprim-sulfamethoxazole or respiratory fluoroquinolones in the past three months are at least four times more likely than those without such exposure to be infected with a pneumococcal isolate that is resistant to the same class of antibiotics.
